Literature DB >> 420255

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients.

L H Noel, M Zanetti, D Droz, C Barbanel.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 420255     DOI: 10.1016/0002-9343(79)90486-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  29 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  c-mip impairs podocyte proximal signaling and induces heavy proteinuria.

Authors:  Shao-Yu Zhang; Maud Kamal; Karine Dahan; André Pawlak; Virginie Ory; Dominique Desvaux; Vincent Audard; Marina Candelier; Fatima BenMohamed; Fatima Ben Mohamed; Marie Matignon; Christo Christov; Xavier Decrouy; Veronique Bernard; Gilles Mangiapan; Philippe Lang; Georges Guellaën; Pierre Ronco; Djillali Sahali
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

4.  Relapse and its remission in Japanese patients with idiopathic membranous nephropathy.

Authors:  Shinji Kitajima; Kengo Furuichi; Norihiko Sakai; Akihiro Sagara; Yasuyuki Shinozaki; Tadashi Toyama; Yasunori Iwata; Miho Shimizu; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2014-06-24       Impact factor: 2.801

5.  Signficance of tubulointerstitial lesions in kidney biopsy specimen of nephrotic patients in Iraq.

Authors:  Abbas Ali Mansour; Ihsan Al-Shamma
Journal:  MedGenMed       Date:  2006-01-10

Review 6.  Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management.

Authors:  Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

7.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

8.  Membranous nephropathy: high-dose alternate-day therapy with prednisone.

Authors:  J Hopper; C G Biava; W H Tu
Journal:  West J Med       Date:  1981-07

9.  Idiopathic membranous glomerulonephritis: aspects of geographical differences.

Authors:  S Abe; Y Amagasaki; K Konishi; E Kato; S Iyori; H Sakaguchi
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

10.  Clinical course and outcome of idiopathic membranous nephropathy in Japanese children.

Authors:  H Tsukahara; Y Takahashi; M Yoshimoto; S Hayashi; S Fujisawa; F Suehiro; K Akaishi; Y Nomura; K Morikawa; M Sudo
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.